NITI AMIN: Open Payments
NPI 1114356573 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 41 payments from 12 companies in 2025. Trend: 2023 $2,293 · 2024 $1,551 · 2025 $929
Food & beverage: $829Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $165 |
| ABBVIE INC. | 10 | $151 |
| Galderma Laboratories, L.P. | 2 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| LEO Pharma Inc. | 2 | $49 |
| STRATA Skin Sciences, Inc. | 3 | $36 |
| GENZYME CORPORATION | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, LEVULAN KERASTICK, COSENTYX, XTRAC, RINVOQ, ILUMYA.
Industry payments across FL — which companies pay providers there.
